nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunisolide—NR3C1—Medroxyprogesterone Acetate—uterine cancer	0.21	0.509	CbGbCtD
Flunisolide—NR3C1—Progesterone—uterine cancer	0.139	0.337	CbGbCtD
Flunisolide—Flurandrenolide—Medroxyprogesterone Acetate—uterine cancer	0.0943	0.197	CrCrCtD
Flunisolide—Prednicarbate—Medroxyprogesterone Acetate—uterine cancer	0.0829	0.173	CrCrCtD
Flunisolide—Fluorometholone—Medroxyprogesterone Acetate—uterine cancer	0.069	0.144	CrCrCtD
Flunisolide—Methylprednisolone—Medroxyprogesterone Acetate—uterine cancer	0.0645	0.135	CrCrCtD
Flunisolide—Hydrocortisone—Medroxyprogesterone Acetate—uterine cancer	0.0606	0.126	CrCrCtD
Flunisolide—Prednisolone—Progesterone—uterine cancer	0.055	0.115	CrCrCtD
Flunisolide—Hydrocortisone—Progesterone—uterine cancer	0.0528	0.11	CrCrCtD
Flunisolide—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0292	0.071	CbGbCtD
Flunisolide—CYP3A4—Progesterone—uterine cancer	0.0194	0.047	CbGbCtD
Flunisolide—CYP3A4—Etoposide—uterine cancer	0.00867	0.0211	CbGbCtD
Flunisolide—CYP3A4—Doxorubicin—uterine cancer	0.00591	0.0144	CbGbCtD
Flunisolide—SERPINA6—oviduct—uterine cancer	0.00449	0.358	CbGeAlD
Flunisolide—SERPINA6—renal system—uterine cancer	0.00105	0.0834	CbGeAlD
Flunisolide—SERPINA6—female reproductive system—uterine cancer	0.000838	0.0668	CbGeAlD
Flunisolide—NR3C1—myometrium—uterine cancer	0.00063	0.0502	CbGeAlD
Flunisolide—NR3C1—epithelium—uterine cancer	0.000494	0.0394	CbGeAlD
Flunisolide—NR3C1—uterine cervix—uterine cancer	0.00049	0.0391	CbGeAlD
Flunisolide—NR3C1—smooth muscle tissue—uterine cancer	0.000476	0.038	CbGeAlD
Flunisolide—NR3C1—decidua—uterine cancer	0.000467	0.0372	CbGeAlD
Flunisolide—NR3C1—renal system—uterine cancer	0.000458	0.0365	CbGeAlD
Flunisolide—NR3C1—endometrium—uterine cancer	0.000443	0.0353	CbGeAlD
Flunisolide—NR3C1—mammalian vulva—uterine cancer	0.000429	0.0342	CbGeAlD
Flunisolide—NR3C1—uterus—uterine cancer	0.000408	0.0325	CbGeAlD
Flunisolide—Fluticasone Propionate—PGR—uterine cancer	0.000397	0.241	CrCbGaD
Flunisolide—NR3C1—female reproductive system—uterine cancer	0.000367	0.0293	CbGeAlD
Flunisolide—Betamethasone—PGR—uterine cancer	0.000364	0.221	CrCbGaD
Flunisolide—CYP3A4—renal system—uterine cancer	0.000347	0.0276	CbGeAlD
Flunisolide—NR3C1—female gonad—uterine cancer	0.000334	0.0266	CbGeAlD
Flunisolide—NR3C1—vagina—uterine cancer	0.000332	0.0265	CbGeAlD
Flunisolide—Dexamethasone—CYP11A1—uterine cancer	0.000281	0.17	CrCbGaD
Flunisolide—CYP3A4—female reproductive system—uterine cancer	0.000278	0.0221	CbGeAlD
Flunisolide—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.000254	0.00267	CcSEcCtD
Flunisolide—Dyspepsia—Progesterone—uterine cancer	0.000253	0.00266	CcSEcCtD
Flunisolide—Cough increased—Epirubicin—uterine cancer	0.000252	0.00265	CcSEcCtD
Flunisolide—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.000252	0.00265	CcSEcCtD
Flunisolide—Glossitis—Epirubicin—uterine cancer	0.000251	0.00264	CcSEcCtD
Flunisolide—Lacrimation increased—Epirubicin—uterine cancer	0.000251	0.00264	CcSEcCtD
Flunisolide—Decreased appetite—Progesterone—uterine cancer	0.00025	0.00263	CcSEcCtD
Flunisolide—Betamethasone—CYP19A1—uterine cancer	0.00025	0.151	CrCbGaD
Flunisolide—Fatigue—Progesterone—uterine cancer	0.000248	0.00261	CcSEcCtD
Flunisolide—Pain—Progesterone—uterine cancer	0.000246	0.00258	CcSEcCtD
Flunisolide—Constipation—Progesterone—uterine cancer	0.000246	0.00258	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000237	0.00249	CcSEcCtD
Flunisolide—Feeling abnormal—Progesterone—uterine cancer	0.000237	0.00249	CcSEcCtD
Flunisolide—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000236	0.00248	CcSEcCtD
Flunisolide—Gastrointestinal pain—Progesterone—uterine cancer	0.000235	0.00247	CcSEcCtD
Flunisolide—Neck pain—Epirubicin—uterine cancer	0.000234	0.00246	CcSEcCtD
Flunisolide—Cough increased—Doxorubicin—uterine cancer	0.000234	0.00245	CcSEcCtD
Flunisolide—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000232	0.00244	CcSEcCtD
Flunisolide—Glossitis—Doxorubicin—uterine cancer	0.000232	0.00244	CcSEcCtD
Flunisolide—Lacrimation increased—Doxorubicin—uterine cancer	0.000232	0.00244	CcSEcCtD
Flunisolide—Pneumonia—Etoposide—uterine cancer	0.000232	0.00244	CcSEcCtD
Flunisolide—Vaginal inflammation—Epirubicin—uterine cancer	0.000231	0.00243	CcSEcCtD
Flunisolide—Ill-defined disorder—Dactinomycin—uterine cancer	0.000231	0.00243	CcSEcCtD
Flunisolide—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000229	0.00241	CcSEcCtD
Flunisolide—Urticaria—Progesterone—uterine cancer	0.000228	0.0024	CcSEcCtD
Flunisolide—Abdominal pain—Progesterone—uterine cancer	0.000227	0.00239	CcSEcCtD
Flunisolide—Body temperature increased—Progesterone—uterine cancer	0.000227	0.00239	CcSEcCtD
Flunisolide—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000226	0.00238	CcSEcCtD
Flunisolide—Stomatitis—Etoposide—uterine cancer	0.000225	0.00236	CcSEcCtD
Flunisolide—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000225	0.00236	CcSEcCtD
Flunisolide—Malaise—Dactinomycin—uterine cancer	0.000225	0.00236	CcSEcCtD
Flunisolide—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000223	0.00234	CcSEcCtD
Flunisolide—Candida infection—Epirubicin—uterine cancer	0.000221	0.00232	CcSEcCtD
Flunisolide—Vaginal infection—Epirubicin—uterine cancer	0.000218	0.00229	CcSEcCtD
Flunisolide—Neck pain—Doxorubicin—uterine cancer	0.000216	0.00227	CcSEcCtD
Flunisolide—NR3C1—lymph node—uterine cancer	0.000215	0.0171	CbGeAlD
Flunisolide—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000215	0.00226	CcSEcCtD
Flunisolide—Vaginal inflammation—Doxorubicin—uterine cancer	0.000214	0.00225	CcSEcCtD
Flunisolide—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000213	0.00224	CcSEcCtD
Flunisolide—Myalgia—Dactinomycin—uterine cancer	0.000212	0.00223	CcSEcCtD
Flunisolide—Hypersensitivity—Progesterone—uterine cancer	0.000212	0.00223	CcSEcCtD
Flunisolide—Dexamethasone—PGR—uterine cancer	0.000212	0.128	CrCbGaD
Flunisolide—Discomfort—Dactinomycin—uterine cancer	0.000209	0.0022	CcSEcCtD
Flunisolide—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000207	0.00218	CcSEcCtD
Flunisolide—Asthenia—Progesterone—uterine cancer	0.000206	0.00217	CcSEcCtD
Flunisolide—Hypoaesthesia—Etoposide—uterine cancer	0.000206	0.00216	CcSEcCtD
Flunisolide—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000206	0.00216	CcSEcCtD
Flunisolide—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000206	0.00216	CcSEcCtD
Flunisolide—Candida infection—Doxorubicin—uterine cancer	0.000204	0.00215	CcSEcCtD
Flunisolide—Pruritus—Progesterone—uterine cancer	0.000203	0.00214	CcSEcCtD
Flunisolide—Oedema—Dactinomycin—uterine cancer	0.000203	0.00214	CcSEcCtD
Flunisolide—Infection—Dactinomycin—uterine cancer	0.000202	0.00212	CcSEcCtD
Flunisolide—Vaginal infection—Doxorubicin—uterine cancer	0.000202	0.00212	CcSEcCtD
Flunisolide—Diarrhoea—Progesterone—uterine cancer	0.000197	0.00207	CcSEcCtD
Flunisolide—Lymphadenopathy—Epirubicin—uterine cancer	0.000197	0.00207	CcSEcCtD
Flunisolide—Erythema multiforme—Etoposide—uterine cancer	0.000196	0.00206	CcSEcCtD
Flunisolide—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000192	0.00202	CcSEcCtD
Flunisolide—Dizziness—Progesterone—uterine cancer	0.00019	0.002	CcSEcCtD
Flunisolide—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000187	0.00196	CcSEcCtD
Flunisolide—Eczema—Epirubicin—uterine cancer	0.000187	0.00196	CcSEcCtD
Flunisolide—Chills—Etoposide—uterine cancer	0.000186	0.00195	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000185	0.00195	CcSEcCtD
Flunisolide—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000184	0.00194	CcSEcCtD
Flunisolide—Vomiting—Progesterone—uterine cancer	0.000183	0.00192	CcSEcCtD
Flunisolide—Lymphadenopathy—Doxorubicin—uterine cancer	0.000182	0.00191	CcSEcCtD
Flunisolide—Rash—Progesterone—uterine cancer	0.000181	0.00191	CcSEcCtD
Flunisolide—Dermatitis—Progesterone—uterine cancer	0.000181	0.0019	CcSEcCtD
Flunisolide—Headache—Progesterone—uterine cancer	0.00018	0.00189	CcSEcCtD
Flunisolide—Increased appetite—Epirubicin—uterine cancer	0.000179	0.00188	CcSEcCtD
Flunisolide—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000178	0.00187	CcSEcCtD
Flunisolide—Decreased appetite—Dactinomycin—uterine cancer	0.000177	0.00186	CcSEcCtD
Flunisolide—Dysgeusia—Etoposide—uterine cancer	0.000176	0.00185	CcSEcCtD
Flunisolide—Fatigue—Dactinomycin—uterine cancer	0.000175	0.00184	CcSEcCtD
Flunisolide—Back pain—Etoposide—uterine cancer	0.000174	0.00183	CcSEcCtD
Flunisolide—Pain—Dactinomycin—uterine cancer	0.000174	0.00183	CcSEcCtD
Flunisolide—Eczema—Doxorubicin—uterine cancer	0.000173	0.00182	CcSEcCtD
Flunisolide—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000172	0.00181	CcSEcCtD
Flunisolide—Nausea—Progesterone—uterine cancer	0.000171	0.00179	CcSEcCtD
Flunisolide—Feeling abnormal—Dactinomycin—uterine cancer	0.000167	0.00176	CcSEcCtD
Flunisolide—Ill-defined disorder—Etoposide—uterine cancer	0.000167	0.00176	CcSEcCtD
Flunisolide—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000166	0.00175	CcSEcCtD
Flunisolide—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000166	0.00174	CcSEcCtD
Flunisolide—Increased appetite—Doxorubicin—uterine cancer	0.000165	0.00174	CcSEcCtD
Flunisolide—Migraine—Epirubicin—uterine cancer	0.000165	0.00174	CcSEcCtD
Flunisolide—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000164	0.00173	CcSEcCtD
Flunisolide—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000164	0.00172	CcSEcCtD
Flunisolide—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000163	0.00172	CcSEcCtD
Flunisolide—Malaise—Etoposide—uterine cancer	0.000162	0.00171	CcSEcCtD
Flunisolide—Vertigo—Etoposide—uterine cancer	0.000162	0.0017	CcSEcCtD
Flunisolide—Abdominal pain—Dactinomycin—uterine cancer	0.000161	0.00169	CcSEcCtD
Flunisolide—Body temperature increased—Dactinomycin—uterine cancer	0.000161	0.00169	CcSEcCtD
Flunisolide—Loss of consciousness—Etoposide—uterine cancer	0.000158	0.00166	CcSEcCtD
Flunisolide—Cough—Etoposide—uterine cancer	0.000157	0.00165	CcSEcCtD
Flunisolide—Hypertension—Etoposide—uterine cancer	0.000156	0.00164	CcSEcCtD
Flunisolide—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000155	0.00163	CcSEcCtD
Flunisolide—Chest pain—Etoposide—uterine cancer	0.000153	0.00161	CcSEcCtD
Flunisolide—Migraine—Doxorubicin—uterine cancer	0.000153	0.00161	CcSEcCtD
Flunisolide—Discomfort—Etoposide—uterine cancer	0.000152	0.00159	CcSEcCtD
Flunisolide—Nasopharyngitis—Epirubicin—uterine cancer	0.00015	0.00158	CcSEcCtD
Flunisolide—Hypersensitivity—Dactinomycin—uterine cancer	0.00015	0.00157	CcSEcCtD
Flunisolide—Infection—Etoposide—uterine cancer	0.000146	0.00154	CcSEcCtD
Flunisolide—Abdominal distension—Epirubicin—uterine cancer	0.000146	0.00153	CcSEcCtD
Flunisolide—Asthenia—Dactinomycin—uterine cancer	0.000146	0.00153	CcSEcCtD
Flunisolide—Dexamethasone—CYP19A1—uterine cancer	0.000145	0.0881	CrCbGaD
Flunisolide—Tachycardia—Etoposide—uterine cancer	0.000144	0.00151	CcSEcCtD
Flunisolide—Hyperhidrosis—Etoposide—uterine cancer	0.000142	0.00149	CcSEcCtD
Flunisolide—Bronchitis—Epirubicin—uterine cancer	0.000139	0.00147	CcSEcCtD
Flunisolide—Diarrhoea—Dactinomycin—uterine cancer	0.000139	0.00146	CcSEcCtD
Flunisolide—Nasopharyngitis—Doxorubicin—uterine cancer	0.000139	0.00146	CcSEcCtD
Flunisolide—Abdominal distension—Doxorubicin—uterine cancer	0.000135	0.00142	CcSEcCtD
Flunisolide—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000135	0.00142	CcSEcCtD
Flunisolide—Weight increased—Epirubicin—uterine cancer	0.000132	0.00139	CcSEcCtD
Flunisolide—Dyspnoea—Etoposide—uterine cancer	0.000131	0.00138	CcSEcCtD
Flunisolide—Pneumonia—Epirubicin—uterine cancer	0.00013	0.00137	CcSEcCtD
Flunisolide—Vomiting—Dactinomycin—uterine cancer	0.000129	0.00136	CcSEcCtD
Flunisolide—Bronchitis—Doxorubicin—uterine cancer	0.000129	0.00136	CcSEcCtD
Flunisolide—Rash—Dactinomycin—uterine cancer	0.000128	0.00135	CcSEcCtD
Flunisolide—Decreased appetite—Etoposide—uterine cancer	0.000128	0.00134	CcSEcCtD
Flunisolide—Fatigue—Etoposide—uterine cancer	0.000127	0.00133	CcSEcCtD
Flunisolide—Stomatitis—Epirubicin—uterine cancer	0.000126	0.00132	CcSEcCtD
Flunisolide—Constipation—Etoposide—uterine cancer	0.000126	0.00132	CcSEcCtD
Flunisolide—Pain—Etoposide—uterine cancer	0.000126	0.00132	CcSEcCtD
Flunisolide—Conjunctivitis—Epirubicin—uterine cancer	0.000126	0.00132	CcSEcCtD
Flunisolide—Urinary tract infection—Epirubicin—uterine cancer	0.000126	0.00132	CcSEcCtD
Flunisolide—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000125	0.00131	CcSEcCtD
Flunisolide—Sweating—Epirubicin—uterine cancer	0.000124	0.0013	CcSEcCtD
Flunisolide—Weight increased—Doxorubicin—uterine cancer	0.000122	0.00128	CcSEcCtD
Flunisolide—Epistaxis—Epirubicin—uterine cancer	0.000122	0.00128	CcSEcCtD
Flunisolide—Sinusitis—Epirubicin—uterine cancer	0.000121	0.00127	CcSEcCtD
Flunisolide—Feeling abnormal—Etoposide—uterine cancer	0.000121	0.00127	CcSEcCtD
Flunisolide—Nausea—Dactinomycin—uterine cancer	0.000121	0.00127	CcSEcCtD
Flunisolide—Pneumonia—Doxorubicin—uterine cancer	0.00012	0.00126	CcSEcCtD
Flunisolide—Gastrointestinal pain—Etoposide—uterine cancer	0.00012	0.00126	CcSEcCtD
Flunisolide—Urticaria—Etoposide—uterine cancer	0.000117	0.00123	CcSEcCtD
Flunisolide—Stomatitis—Doxorubicin—uterine cancer	0.000117	0.00123	CcSEcCtD
Flunisolide—Rhinitis—Epirubicin—uterine cancer	0.000116	0.00122	CcSEcCtD
Flunisolide—Abdominal pain—Etoposide—uterine cancer	0.000116	0.00122	CcSEcCtD
Flunisolide—Body temperature increased—Etoposide—uterine cancer	0.000116	0.00122	CcSEcCtD
Flunisolide—Conjunctivitis—Doxorubicin—uterine cancer	0.000116	0.00122	CcSEcCtD
Flunisolide—Urinary tract infection—Doxorubicin—uterine cancer	0.000116	0.00122	CcSEcCtD
Flunisolide—Hypoaesthesia—Epirubicin—uterine cancer	0.000115	0.00121	CcSEcCtD
Flunisolide—Pharyngitis—Epirubicin—uterine cancer	0.000115	0.00121	CcSEcCtD
Flunisolide—Sweating—Doxorubicin—uterine cancer	0.000115	0.00121	CcSEcCtD
Flunisolide—Oedema peripheral—Epirubicin—uterine cancer	0.000114	0.0012	CcSEcCtD
Flunisolide—Epistaxis—Doxorubicin—uterine cancer	0.000113	0.00119	CcSEcCtD
Flunisolide—Sinusitis—Doxorubicin—uterine cancer	0.000112	0.00118	CcSEcCtD
Flunisolide—Erythema multiforme—Epirubicin—uterine cancer	0.00011	0.00115	CcSEcCtD
Flunisolide—Hypersensitivity—Etoposide—uterine cancer	0.000108	0.00114	CcSEcCtD
Flunisolide—Rhinitis—Doxorubicin—uterine cancer	0.000108	0.00113	CcSEcCtD
Flunisolide—Hypoaesthesia—Doxorubicin—uterine cancer	0.000107	0.00112	CcSEcCtD
Flunisolide—Pharyngitis—Doxorubicin—uterine cancer	0.000107	0.00112	CcSEcCtD
Flunisolide—Oedema peripheral—Doxorubicin—uterine cancer	0.000106	0.00111	CcSEcCtD
Flunisolide—Asthenia—Etoposide—uterine cancer	0.000106	0.00111	CcSEcCtD
Flunisolide—Chills—Epirubicin—uterine cancer	0.000104	0.00109	CcSEcCtD
Flunisolide—Pruritus—Etoposide—uterine cancer	0.000104	0.00109	CcSEcCtD
Flunisolide—Erythema multiforme—Doxorubicin—uterine cancer	0.000102	0.00107	CcSEcCtD
Flunisolide—Malnutrition—Epirubicin—uterine cancer	0.000101	0.00106	CcSEcCtD
Flunisolide—Diarrhoea—Etoposide—uterine cancer	0.000101	0.00106	CcSEcCtD
Flunisolide—Dysgeusia—Epirubicin—uterine cancer	9.89e-05	0.00104	CcSEcCtD
Flunisolide—Back pain—Epirubicin—uterine cancer	9.77e-05	0.00103	CcSEcCtD
Flunisolide—Dizziness—Etoposide—uterine cancer	9.72e-05	0.00102	CcSEcCtD
Flunisolide—Chills—Doxorubicin—uterine cancer	9.63e-05	0.00101	CcSEcCtD
Flunisolide—Vision blurred—Epirubicin—uterine cancer	9.52e-05	0.001	CcSEcCtD
Flunisolide—Ill-defined disorder—Epirubicin—uterine cancer	9.37e-05	0.000985	CcSEcCtD
Flunisolide—Vomiting—Etoposide—uterine cancer	9.35e-05	0.000983	CcSEcCtD
Flunisolide—Malnutrition—Doxorubicin—uterine cancer	9.35e-05	0.000982	CcSEcCtD
Flunisolide—Agitation—Epirubicin—uterine cancer	9.28e-05	0.000976	CcSEcCtD
Flunisolide—Rash—Etoposide—uterine cancer	9.27e-05	0.000975	CcSEcCtD
Flunisolide—Dermatitis—Etoposide—uterine cancer	9.26e-05	0.000974	CcSEcCtD
Flunisolide—Headache—Etoposide—uterine cancer	9.21e-05	0.000968	CcSEcCtD
Flunisolide—Dysgeusia—Doxorubicin—uterine cancer	9.15e-05	0.000962	CcSEcCtD
Flunisolide—Malaise—Epirubicin—uterine cancer	9.11e-05	0.000957	CcSEcCtD
Flunisolide—Vertigo—Epirubicin—uterine cancer	9.07e-05	0.000954	CcSEcCtD
Flunisolide—Syncope—Epirubicin—uterine cancer	9.06e-05	0.000952	CcSEcCtD
Flunisolide—Back pain—Doxorubicin—uterine cancer	9.04e-05	0.00095	CcSEcCtD
Flunisolide—Palpitations—Epirubicin—uterine cancer	8.93e-05	0.000938	CcSEcCtD
Flunisolide—Loss of consciousness—Epirubicin—uterine cancer	8.88e-05	0.000933	CcSEcCtD
Flunisolide—Cough—Epirubicin—uterine cancer	8.81e-05	0.000926	CcSEcCtD
Flunisolide—Vision blurred—Doxorubicin—uterine cancer	8.81e-05	0.000926	CcSEcCtD
Flunisolide—Nausea—Etoposide—uterine cancer	8.74e-05	0.000918	CcSEcCtD
Flunisolide—Hypertension—Epirubicin—uterine cancer	8.72e-05	0.000917	CcSEcCtD
Flunisolide—Ill-defined disorder—Doxorubicin—uterine cancer	8.67e-05	0.000911	CcSEcCtD
Flunisolide—Myalgia—Epirubicin—uterine cancer	8.6e-05	0.000904	CcSEcCtD
Flunisolide—Chest pain—Epirubicin—uterine cancer	8.6e-05	0.000904	CcSEcCtD
Flunisolide—Agitation—Doxorubicin—uterine cancer	8.59e-05	0.000903	CcSEcCtD
Flunisolide—Anxiety—Epirubicin—uterine cancer	8.57e-05	0.000901	CcSEcCtD
Flunisolide—Discomfort—Epirubicin—uterine cancer	8.5e-05	0.000893	CcSEcCtD
Flunisolide—Malaise—Doxorubicin—uterine cancer	8.43e-05	0.000886	CcSEcCtD
Flunisolide—Vertigo—Doxorubicin—uterine cancer	8.4e-05	0.000883	CcSEcCtD
Flunisolide—Syncope—Doxorubicin—uterine cancer	8.38e-05	0.000881	CcSEcCtD
Flunisolide—Palpitations—Doxorubicin—uterine cancer	8.26e-05	0.000868	CcSEcCtD
Flunisolide—Oedema—Epirubicin—uterine cancer	8.24e-05	0.000866	CcSEcCtD
Flunisolide—Loss of consciousness—Doxorubicin—uterine cancer	8.21e-05	0.000863	CcSEcCtD
Flunisolide—Infection—Epirubicin—uterine cancer	8.19e-05	0.000861	CcSEcCtD
Flunisolide—Cough—Doxorubicin—uterine cancer	8.16e-05	0.000857	CcSEcCtD
Flunisolide—Shock—Epirubicin—uterine cancer	8.11e-05	0.000852	CcSEcCtD
Flunisolide—Hypertension—Doxorubicin—uterine cancer	8.07e-05	0.000848	CcSEcCtD
Flunisolide—Tachycardia—Epirubicin—uterine cancer	8.05e-05	0.000846	CcSEcCtD
Flunisolide—Hyperhidrosis—Epirubicin—uterine cancer	7.97e-05	0.000838	CcSEcCtD
Flunisolide—Myalgia—Doxorubicin—uterine cancer	7.96e-05	0.000836	CcSEcCtD
Flunisolide—Chest pain—Doxorubicin—uterine cancer	7.96e-05	0.000836	CcSEcCtD
Flunisolide—Anxiety—Doxorubicin—uterine cancer	7.93e-05	0.000833	CcSEcCtD
Flunisolide—Discomfort—Doxorubicin—uterine cancer	7.86e-05	0.000826	CcSEcCtD
Flunisolide—Oedema—Doxorubicin—uterine cancer	7.63e-05	0.000802	CcSEcCtD
Flunisolide—Infection—Doxorubicin—uterine cancer	7.58e-05	0.000796	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Epirubicin—uterine cancer	7.51e-05	0.000789	CcSEcCtD
Flunisolide—Shock—Doxorubicin—uterine cancer	7.5e-05	0.000789	CcSEcCtD
Flunisolide—Insomnia—Epirubicin—uterine cancer	7.46e-05	0.000784	CcSEcCtD
Flunisolide—Tachycardia—Doxorubicin—uterine cancer	7.44e-05	0.000782	CcSEcCtD
Flunisolide—Hyperhidrosis—Doxorubicin—uterine cancer	7.37e-05	0.000775	CcSEcCtD
Flunisolide—Dyspnoea—Epirubicin—uterine cancer	7.35e-05	0.000772	CcSEcCtD
Flunisolide—Dyspepsia—Epirubicin—uterine cancer	7.26e-05	0.000763	CcSEcCtD
Flunisolide—Decreased appetite—Epirubicin—uterine cancer	7.17e-05	0.000753	CcSEcCtD
Flunisolide—Fatigue—Epirubicin—uterine cancer	7.11e-05	0.000747	CcSEcCtD
Flunisolide—Pain—Epirubicin—uterine cancer	7.05e-05	0.000741	CcSEcCtD
Flunisolide—Constipation—Epirubicin—uterine cancer	7.05e-05	0.000741	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Doxorubicin—uterine cancer	6.95e-05	0.00073	CcSEcCtD
Flunisolide—Insomnia—Doxorubicin—uterine cancer	6.9e-05	0.000725	CcSEcCtD
Flunisolide—Dyspnoea—Doxorubicin—uterine cancer	6.8e-05	0.000715	CcSEcCtD
Flunisolide—Feeling abnormal—Epirubicin—uterine cancer	6.79e-05	0.000714	CcSEcCtD
Flunisolide—Gastrointestinal pain—Epirubicin—uterine cancer	6.74e-05	0.000709	CcSEcCtD
Flunisolide—Dyspepsia—Doxorubicin—uterine cancer	6.71e-05	0.000706	CcSEcCtD
Flunisolide—Decreased appetite—Doxorubicin—uterine cancer	6.63e-05	0.000697	CcSEcCtD
Flunisolide—Fatigue—Doxorubicin—uterine cancer	6.58e-05	0.000691	CcSEcCtD
Flunisolide—Urticaria—Epirubicin—uterine cancer	6.55e-05	0.000688	CcSEcCtD
Flunisolide—Pain—Doxorubicin—uterine cancer	6.52e-05	0.000686	CcSEcCtD
Flunisolide—Constipation—Doxorubicin—uterine cancer	6.52e-05	0.000686	CcSEcCtD
Flunisolide—Abdominal pain—Epirubicin—uterine cancer	6.52e-05	0.000685	CcSEcCtD
Flunisolide—Body temperature increased—Epirubicin—uterine cancer	6.52e-05	0.000685	CcSEcCtD
Flunisolide—Feeling abnormal—Doxorubicin—uterine cancer	6.29e-05	0.000661	CcSEcCtD
Flunisolide—Gastrointestinal pain—Doxorubicin—uterine cancer	6.24e-05	0.000656	CcSEcCtD
Flunisolide—Hypersensitivity—Epirubicin—uterine cancer	6.07e-05	0.000638	CcSEcCtD
Flunisolide—Urticaria—Doxorubicin—uterine cancer	6.06e-05	0.000637	CcSEcCtD
Flunisolide—Body temperature increased—Doxorubicin—uterine cancer	6.03e-05	0.000634	CcSEcCtD
Flunisolide—Abdominal pain—Doxorubicin—uterine cancer	6.03e-05	0.000634	CcSEcCtD
Flunisolide—Asthenia—Epirubicin—uterine cancer	5.91e-05	0.000622	CcSEcCtD
Flunisolide—Pruritus—Epirubicin—uterine cancer	5.83e-05	0.000613	CcSEcCtD
Flunisolide—Diarrhoea—Epirubicin—uterine cancer	5.64e-05	0.000593	CcSEcCtD
Flunisolide—Hypersensitivity—Doxorubicin—uterine cancer	5.62e-05	0.000591	CcSEcCtD
Flunisolide—Asthenia—Doxorubicin—uterine cancer	5.47e-05	0.000575	CcSEcCtD
Flunisolide—Dizziness—Epirubicin—uterine cancer	5.45e-05	0.000573	CcSEcCtD
Flunisolide—Pruritus—Doxorubicin—uterine cancer	5.4e-05	0.000567	CcSEcCtD
Flunisolide—Vomiting—Epirubicin—uterine cancer	5.24e-05	0.000551	CcSEcCtD
Flunisolide—Diarrhoea—Doxorubicin—uterine cancer	5.22e-05	0.000549	CcSEcCtD
Flunisolide—Rash—Epirubicin—uterine cancer	5.2e-05	0.000546	CcSEcCtD
Flunisolide—Dermatitis—Epirubicin—uterine cancer	5.19e-05	0.000546	CcSEcCtD
Flunisolide—Headache—Epirubicin—uterine cancer	5.16e-05	0.000543	CcSEcCtD
Flunisolide—Dizziness—Doxorubicin—uterine cancer	5.04e-05	0.00053	CcSEcCtD
Flunisolide—Nausea—Epirubicin—uterine cancer	4.9e-05	0.000515	CcSEcCtD
Flunisolide—Vomiting—Doxorubicin—uterine cancer	4.85e-05	0.00051	CcSEcCtD
Flunisolide—Rash—Doxorubicin—uterine cancer	4.81e-05	0.000505	CcSEcCtD
Flunisolide—Dermatitis—Doxorubicin—uterine cancer	4.8e-05	0.000505	CcSEcCtD
Flunisolide—Headache—Doxorubicin—uterine cancer	4.78e-05	0.000502	CcSEcCtD
Flunisolide—Nausea—Doxorubicin—uterine cancer	4.53e-05	0.000476	CcSEcCtD
